Institutions / Exome Asset Management LLC / Holdings
Back to Exome Asset Management LLC

Exome Asset Management LLC

All holdings · as of Dec 31, 2025

53 positions

CompanyClassValueShares% of portfolio
Praxis Precision Medicines, Inc.—$17.13M58,1228.5%
Cogent Biosciences, Inc.—$10.85M305,5685.4%
Guardant Health, Inc.—$10.03M98,1825.0%
IONIS PHARMACEUTICALS INC—$9.22M116,5154.6%
ELI LILLY & Co—$8.44M7,8524.2%
Cytokinetics Inc—$7.93M124,7493.9%
WAVE LIFE SCIENCES LTD—$7.17M421,4883.5%
Vera Therapeutics, Inc.—$6.30M124,3913.1%
BridgeBio Pharma, Inc.—$6.17M80,7233.1%
Elevance Health Inc—$6.03M17,1913.0%
ASTRAZENECA PLC—$5.26M28,3622.6%
Jazz Pharmaceuticals PLC—$4.50M26,4942.2%
Natera, Inc.—$4.27M18,6502.1%
Immunovant, Inc.IMVTCommon Stock$4.03M158,6222.0%
UNIVERSAL HEALTH SERVICES INC—$3.84M17,6281.9%
United Therapeutics Corp—$3.74M7,6851.8%
AGIOS PHARMACEUTICALS, INC.—$3.73M136,9421.8%
Disc Medicine, Inc.IRONCommon Stock$3.71M46,7431.8%
Intuitive Surgical Inc—$3.60M6,3581.8%
Glaukos Corp—$3.55M31,4711.8%
Enliven Therapeutics, Inc.ELVNCommon Stock$3.42M222,3081.7%
Celcuity Inc.CELCCommon Stock$3.42M34,2891.7%
Apellis Pharmaceuticals, Inc.—$3.41M135,8491.7%
Travere Therapeutics, Inc.—$3.40M89,0521.7%
Dexcom Inc—$3.33M50,1471.6%
ARROWHEAD PHARMACEUTICALS, INC.—$3.30M49,7581.6%
CytomX Therapeutics, Inc.—$3.17M745,3051.6%
Liquidia CorpLQDACommon Stock$3.14M91,1481.6%
Verastem, Inc.—$3.10M401,7431.5%
ALUMIS INC.ALMSCommon Stock$2.85M292,2501.4%
Penumbra Inc—$2.80M9,0001.4%
10x Genomics, Inc.—$2.67M163,6581.3%
IMMUNOCORE HOLDINGS PLC-ADRIMCRADR$2.66M76,7501.3%
Edgewise Therapeutics, Inc.—$2.48M100,0461.2%
NextCure, Inc.NXTCCommon Stock$2.34M165,0001.2%
BELITE BIO, INCBLTEADR$2.29M14,3281.1%
Waystar Holding Corp.—$2.26M68,9691.1%
IRONWOOD PHARMACEUTICALS INC—$2.19M648,5321.1%
Karyopharm Therapeutics Inc.—$2.18M295,5411.1%
ADAGENE INC.—$2.00M1,060,2211.0%
NovaBridge BiosciencesNBPADR$1.99M499,5871.0%
UNITEDHEALTH GROUP INC—$1.93M5,8351.0%
PALISADE BIO, INC.—$1.78M758,2030.9%
Upstream Bio, Inc.UPBCommon Stock$1.76M64,8450.9%
Gossamer Bio, Inc.—$1.40M451,6990.7%
Inhibikase Therapeutics, Inc.—$1.23M600,0000.6%
IQVIA HOLDINGS INC.—$1.21M5,3780.6%
TENET HEALTHCARE CORP—$1.21M6,0840.6%
Corbus Pharmaceuticals Holdings, Inc.CRBPCommon Stock$1.14M139,5430.6%
Fulcrum Therapeutics, Inc.—$1.04M92,0550.5%
← PrevPage 1 of 2Next →